Show simple item record

dc.creatorProckop, Darwin J.
dc.creatorOh, Joo Youn
dc.creatorBerkowitz, Barry
dc.creatorRoddy, Gavin W.
dc.creatorRosa, Robert
dc.date.accessioned2019-06-17T17:13:15Z
dc.date.available2019-06-17T17:13:15Z
dc.date.issued2017-08-15
dc.identifier.urihttps://hdl.handle.net/1969.1/177216
dc.description.abstractThe present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleAdult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseasesen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeThe Texas A&M University System
dc.contributor.assigneeTemple Therapeutics, Inc.
dc.contributor.assigneeScott & White Healthcare
dc.identifier.patentapplicationnumber14/825788
dc.subject.uspcprimary514/20.8
dc.date.filed2015-08-13
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryA61K 35/28
dc.subject.cpcprimaryA61K 9/0048
dc.subject.cpcprimaryA61K 9/0051
dc.subject.cpcprimaryA61K 38/1709
dc.subject.cpcprimaryA61K 39/00
dc.subject.cpcprimaryA61K 39/395
dc.subject.cpcprimaryA61K 45/06
dc.subject.cpcprimaryC07K 16/18
dc.subject.cpcprimaryC12N 5/0663
dc.subject.cpcprimaryA61K 2035/124
dc.subject.cpcprimaryC07K 2317/76
dc.subject.cpcprimaryC12N 2501/25
dc.subject.cpcprimaryC12N 2501/48


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record